Tatsuya Atsumi

26.4k total citations · 1 hit paper
512 papers, 15.5k citations indexed

About

Tatsuya Atsumi is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Tatsuya Atsumi has authored 512 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 267 papers in Rheumatology, 117 papers in Immunology and 102 papers in Hematology. Recurrent topics in Tatsuya Atsumi's work include Systemic Lupus Erythematosus Research (178 papers), Rheumatoid Arthritis Research and Therapies (81 papers) and Platelet Disorders and Treatments (68 papers). Tatsuya Atsumi is often cited by papers focused on Systemic Lupus Erythematosus Research (178 papers), Rheumatoid Arthritis Research and Therapies (81 papers) and Platelet Disorders and Treatments (68 papers). Tatsuya Atsumi collaborates with scholars based in Japan, United States and United Kingdom. Tatsuya Atsumi's co-authors include Takayoshi Koike, Olga Amengual, Pier Luigi Meroni, Anǵela Tincani, Steven A. Krilis, Panayiotis G. Vlachoyiannopoulos, Takao Koike, Ricard Cervera, Spiros Miyakis and D. Ware Branch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Tatsuya Atsumi

487 papers receiving 15.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

2006 4.8k citations Tatsuya Atsumi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tatsuya Atsumi Japan	51	9.5k	5.0k	4.2k	1.8k	1.7k	512	15.5k
Anǵela Tincani Italy	71	15.0k 1.6×	5.9k 1.2×	7.2k 1.7×	1.5k 0.8×	2.6k 1.5×	451	21.3k
Jane E. Salmon United States	66	7.8k 0.8×	3.2k 0.6×	6.8k 1.6×	1.7k 1.0×	1.9k 1.2×	211	14.6k
E. William St. Clair United States	55	9.1k 1.0×	3.2k 0.6×	5.3k 1.2×	1.7k 0.9×	677 0.4×	170	16.5k
Manuel Ramos‐Casals Spain	70	7.8k 0.8×	2.0k 0.4×	4.2k 1.0×	1.3k 0.7×	1.0k 0.6×	258	18.2k
Graham R.V. Hughes United Kingdom	68	13.6k 1.4×	4.3k 0.9×	4.4k 1.0×	1.2k 0.7×	1.7k 1.0×	263	18.2k
Zahir Amoura France	75	7.3k 0.8×	1.4k 0.3×	6.3k 1.5×	1.6k 0.9×	1.1k 0.6×	424	17.6k
Dimitrios T. Boumpas Greece	69	7.3k 0.8×	1.4k 0.3×	7.4k 1.7×	2.6k 1.4×	1.7k 1.0×	317	15.5k
Jean‐Charles Piette France	69	6.0k 0.6×	1.8k 0.4×	2.9k 0.7×	2.0k 1.1×	1.2k 0.7×	201	14.1k
Pier Luigi Meroni Italy	81	18.0k 1.9×	7.6k 1.5×	9.0k 2.1×	2.6k 1.4×	3.1k 1.8×	621	28.6k
Jill P. Buyon United States	74	9.8k 1.0×	1.5k 0.3×	7.1k 1.7×	2.0k 1.1×	1.5k 0.9×	320	17.1k

Countries citing papers authored by Tatsuya Atsumi

Since Specialization

Citations

This map shows the geographic impact of Tatsuya Atsumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Atsumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Atsumi more than expected).

Fields of papers citing papers by Tatsuya Atsumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuya Atsumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Atsumi. The network helps show where Tatsuya Atsumi may publish in the future.

Co-authorship network of co-authors of Tatsuya Atsumi

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuya Atsumi. A scholar is included among the top collaborators of Tatsuya Atsumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuya Atsumi. Tatsuya Atsumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kono, Michihito, Ryo Hisada, Yuichiro Fujieda, et al.. (2025). Predictive Factors for Renal Outcome During Remission Induction Treatment Period in Lupus Nephritis. International Journal of Rheumatic Diseases. 28(11). e70470–e70470. 1 indexed citations

Okamoto, Nami, Tatsuya Atsumi, Michiaki Takagi, et al.. (2024). Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study. Modern Rheumatology. 35(2). 215–224. 6 indexed citations

Kameda, Hiraku, Aika Miya, Hiroshi Nomoto, et al.. (2023). Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report. Medicine. 102(51). e36664–e36664. 3 indexed citations

Nomoto, Hiroshi, Hiroki Yokoyama, Yuka Suzuki, et al.. (2023). Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 2 study). Diabetes Obesity and Metabolism. 26(3). 961–970. 8 indexed citations

Takagi, Michiaki, Tatsuya Atsumi, Hiroaki Matsuno, et al.. (2022). Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance. Modern Rheumatology. 33(4). 647–656. 17 indexed citations

Weng, Xinyu, Daiju Iwata, Kenichi Namba, et al.. (2022). Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report. American Journal of Ophthalmology Case Reports. 25. 101333–101333. 5 indexed citations

Ito, Masaki, et al.. (2022). Diagnostic Value of Vessel Wall Imaging to Determine the Timing of Extracranial‒Intracranial Bypass for Moyamoya Syndrome Associated with Active Sjögren's Syndrome: A Case Report. Journal of Neurological Surgery Part A Central European Neurosurgery. 85(2). 227–232. 2 indexed citations

Erkan, Doruk, Savino Sciascia, María Laura Bertolaccini, et al.. (2021). Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current Rheumatology Reports. 23(6). 8 indexed citations

Omori, Kazuno, Akinobu Nakamura, Hideaki Miyoshi, et al.. (2021). Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing β-Cell Mass in db/db Mice. Diabetes. 70(4). 917–931. 16 indexed citations

10.

Fujieda, Yuichiro, Taiki Sato, Naoki Ohnishi, et al.. (2020). Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study. Lara D. Veeken. 60(3). 1331–1337. 13 indexed citations

11.

Fujieda, Yuichiro, Takuya Asaka, Masahiro Ota, et al.. (2020). Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. Journal of Bone and Mineral Metabolism. 38(4). 581–588. 11 indexed citations

12.

Miya, Aika, Akinobu Nakamura, Hideaki Miyoshi, et al.. (2020). Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. Journal of Diabetes Investigation. 11(4). 964–970. 6 indexed citations

13.

Sato, Tetsuro, Hiroyuki Nakamura, Yuichiro Fujieda, et al.. (2019). Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort study. Lupus. 28(13). 1577–1582. 20 indexed citations

14.

Karino, Kohei, Michihito Kono, Keita Sakamoto, et al.. (2019). Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositis. Lara D. Veeken. 59(7). 1734–1742. 15 indexed citations

15.

Kato, Masaru, Shinsuke Yasuda, & Tatsuya Atsumi. (2018). The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?. Rheumatology International. 38(8). 1333–1338. 16 indexed citations

16.

Takahashi, Kiyohiko, Kyu Yong Cho, Akinobu Nakamura, et al.. (2018). Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation. 10(2). 429–438. 7 indexed citations

17.

Fukae, Jun, Kazuhide Tanimura, Masato Isobe, et al.. (2017). Active synovitis in the presence of osteitis predicts residual synovitis in patients with rheumatoid arthritis with a clinical response to treatment. International Journal of Rheumatic Diseases. 21(10). 1809–1814. 1 indexed citations

18.

Kanda, Masatoshi, Hiroyuki Yamanaka, Satoshi Kojo, et al.. (2016). Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production iniNKT cells. Proceedings of the National Academy of Sciences. 113(24). E3394–402. 33 indexed citations

19.

Atsumi, Tatsuya, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.. (2015). The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Annals of the Rheumatic Diseases. 75(1). 75–83. 84 indexed citations

20.

Atsumi, Tatsuya, et al.. (2002). Suppressed intrinsic fibrinolytic activity by monoclonal anti‐beta‐2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome. British Journal of Haematology. 119(3). 781–788. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact